Skip To The Main Content

Press Releases

PDA Announces the Volunteer Members of its 2023 Board of Directors and Officers

For Immediate Release:
Media Inquiries:
Walter Morris
/ [email protected] /

The Parenteral Drug Association (PDA) today announced the volunteer members of its 2023, which will be one of the most geographically diverse in PDA’s history.

Newly elected Directors are:

  • Christiana Campa, PhD, GSK (Italy)
  • Cylia Chen Ooi, Amgen (United States)
  • Marc Gloglovsky, ValSource Inc. (United States)
  • Ivy Louis, VIENNI Taining & Consulting LLP (India)

“The incoming members of the 2023 Board of Directors reflects the growing diversity of PDA’s global membership,” said Richard Johnson, PDA President & CEO. “On behalf of PDA, I would like to congratulate these candidates, and all the qualified members who ran in the 2022 board election.”

The complete 2022-2023 Board of Directors and Officers will be composed of the following volunteers:


  • Chairs: Sue Schniepp, Regulatory Compliance Associates Inc.
  • Chair-Elect: Anil Sawant, Merck & Co./Merck, Sharp & Dohme
  • Treasurer: Melissa Seymour, Biogen, Inc.
  • Secretary: Emma Ramnarine, Genentech/Roche
  • Imm. Past Chair: Jette Christensen, Novo Nordisk


  • Bettine Boltres, West Pharmaceutical Services
  • Christiana Campa, PhD, GSK
  • Javier Camposano, Celltrion
  • Mirko Gabriele, Thermo Fisher Scientific
  • Marc Gloglovsky, ValSource Inc.
  • Andrew Hopkins, Abbvie
  • Stephan Krause, AstraZeneca Biologics
  • Ivy Louis, VIENNI Taining & Consulting LLP
  • Amy McDaniel, Bristol Myers Squibb
  • Cylia Chen Ooi, Amgen
  • Mathias Romacker (ret.)
  • Osamu Shirokizawa, Lifescientia